Related references
Note: Only part of the references are listed.CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
Gwenola Manic et al.
GUT (2018)
Immunometabolism governs dendritic cell and macrophage function
Luke A. J. O'Neill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Federico Pietrocola et al.
CANCER CELL (2016)
DNA Damage-Induced HSPC Malfunction Depends on ROS Accumulation Downstream of IFN-1 Signaling and Bid Mobilization
Alpaslan Tasdogan et al.
CELL STEM CELL (2016)
Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function
Duojiao Wu et al.
IMMUNITY (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
W. Shen et al.
BLOOD (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
Autumn G. York et al.
CELL (2015)
DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity
Anetta Hartlova et al.
IMMUNITY (2015)
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Helen M. Lazear et al.
IMMUNITY (2015)
Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness
Shuqin Li et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Erika Vacchelli et al.
SCIENCE (2015)
β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer
D. Jia et al.
CELL DEATH AND DIFFERENTIATION (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Xuanming Yang et al.
CANCER CELL (2014)
Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
Joanne Y. H. Lim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
Michael J. White et al.
CELL (2014)
Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells
Yifan Zhu et al.
EXPERIMENTAL CELL RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
Thomas R. O'Brien et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Human TLR10 is an anti-inflammatory pattern-recognition receptor
Marije Oosting et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection
Suki M. Y. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Cyclophosphamide Induces a Type I Interferon-Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
Federica Moschella et al.
CLINICAL CANCER RESEARCH (2013)
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs
Katerina I. Leonova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection
Ka Yee Fung et al.
SCIENCE (2013)
Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
Jieun Lee et al.
CELL (2012)
Modulation of T-cell function by type I interferon
David F. Tough
IMMUNOLOGY AND CELL BIOLOGY (2012)
NLRC5: a key regulator of MHC class I-dependent immune responses
Koichi S. Kobayashi et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells
Jeanette E. Boudreau et al.
CANCER RESEARCH (2011)
Pathogen Recognition by the Innate Immune System
Himanshu Kumar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon α Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2
Rebecca A. R. Piganis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming
Silvia Lorenzi et al.
JOURNAL OF IMMUNOLOGY (2011)
Toll-Like Receptors as Interferon-Regulated Genes and Their Role in Disease
Jing Jing Khoo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
Zhiqiang Zhang et al.
NATURE IMMUNOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Interferon-α as angiogenesis inhibitor: Learning from tumor models
Stefano Indraccolo
AUTOIMMUNITY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Interferon-α targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
Min Lu et al.
EXPERIMENTAL HEMATOLOGY (2010)
IFI16 is an innate immune sensor for intracellular DNA
Leonie Unterholzner et al.
NATURE IMMUNOLOGY (2010)
RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Yu-Hsin Chiu et al.
CELL (2009)
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Teresa Fernandes-Alnemri et al.
NATURE (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Activation of innate immune antiviral responses by Nod2
Ahmed Sabbah et al.
NATURE IMMUNOLOGY (2009)
Trex1 prevents cell-intrinsic initiation of autoimmunity
Daniel B. Stetson et al.
CELL (2008)
NLRs at the intersection of cell death and immunity
Jenny P. -Y. Ting et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Enhancement of human melanoma antigen expression by IFN-β
Ian S. Dunn et al.
JOURNAL OF IMMUNOLOGY (2007)
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Akinori Takaoka et al.
NATURE (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The inflammasome: First line of the immune response to cell stress
Yasunori Ogura et al.
CELL (2006)
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA
KJ Ishii et al.
NATURE IMMUNOLOGY (2006)
Complex modulation of cell type-specific signaling in response to type I Interferons
Anette H. H. van Boxel-Dezaire et al.
IMMUNITY (2006)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan et al.
NATURE (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
VISA is an adapter protein required for virus-triggered IFN-β signaling
LG Xu et al.
MOLECULAR CELL (2005)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity
M Yoneyama et al.
JOURNAL OF IMMUNOLOGY (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Medical progress - Management of cutaneous melanoma
H Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Protection against progressive leishmaniasis by IFN-β
J Mattner et al.
JOURNAL OF IMMUNOLOGY (2004)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
H Takayanagi et al.
NATURE (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
L Thyrell et al.
ONCOGENE (2002)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
A Le Bon et al.
IMMUNITY (2001)
Apoptosis and cell growth inhibition as antitumor effector functions of interferons
O Sangfelt et al.
MEDICAL ONCOLOGY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
SM Santini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Mechanisms of interferon-induced cell cycle arrest
O Sangfelt et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2000)
Share Paper
